Regulus Therapeutics
RGLS
#8819
Rank
โ‚ฌ91.82 M
Marketcap
1,40ย โ‚ฌ
Share price
5.00%
Change (1 day)
14.55%
Change (1 year)

Revenue for Regulus Therapeutics (RGLS)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Regulus Therapeutics from 2012 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A
2021 N/A-100%
2020 โ‚ฌ8.13 M33.39%
2019 โ‚ฌ6.09 M9590.19%
2018 โ‚ฌ0.06 M4.88%
2017 โ‚ฌ0.06 M-94.71%
2016 โ‚ฌ1.13 M-94.02%
2015 โ‚ฌ18.98 M201.09%
2014 โ‚ฌ6.3 M-55.5%
2013 โ‚ฌ14.17 M47.59%
2012 โ‚ฌ9.6 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ38.38 BN/A๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ51.02 BN/A๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ9.22 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ46.85 BN/A๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ1.99 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ11.7 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ45.23 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.18 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA